David P. Meeker - 09 Feb 2022 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
President and CEO, Director
Signature
/s/ Hunter C. Smith, attorney-in-fact for David P. Meeker
Issuer symbol
RYTM
Transactions as of
09 Feb 2022
Transactions value $
$0
Form type
4
Filing time
11 Feb 2022, 20:33:43 UTC
Previous filing
17 Jun 2021
Next filing
01 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Stock Option (Right to Buy) Award $0 +510K $0.00 510K 09 Feb 2022 Common Stock 510K $6.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were granted on February 9, 2022. The option vests and becomes exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.